Related Experiment Video
Updated: Jan 15, 2026

In-vitro Reconstitution of Bacterial Ubiquitination and VCP/p97-mediated Elimination
Published on: January 2, 2026
APP ubiquitination by VHL protein is essential for MVB sorting and lysosomal degradation
Chunyan Shan1, Rixu Cong1, Xiangyu Xu1
1Key Laboratory of Cell Proliferation and Differentiation of the Ministry of Education, School of Life Sciences, Peking University, Beijing 100871, China.
Abstract:
Amyloid precursor protein (APP), a type I transmembrane protein, is closely related to the pathogenesis of Alzheimer's disease (AD). Amyloid beta (Aβ) is generated by sequential processing of APP in the Golgi apparatus and endosomes, and its toxicity leads to neuron dysfunction and neurodegeneration. APP is selectively shuttled between intracellular membrane compartments and ultimately transported into lysosomes. However, the mechanisms underlying APP sorting signals and lysosomal degradation are largely unclear. In this study, we show that the von Hippel‒Lindau (VHL) protein, a subunit of an E3 ligase, recognizes the cytoplasmic domain of APP and mediates its ubiquitination. VHL-mediated ubiquitination facilitates the sorting of membrane APP into intraluminal vesicles of multivesicular bodies (MVBs) and subsequent degradation in lysosomes. Therefore, the loss of VHL accelerates Aβ plaque deposition and memory deficits in AD model mice. Our findings reveal the role of VHL in restricting AD pathogenesis through ubiquitination-dependent MVB sorting and lysosomal degradation of APP.
Insights
The von Hippel-Lindau protein (VHL) targets amyloid precursor protein (APP) for degradation, reducing Alzheimer's disease (AD) pathology. Loss of VHL accelerates Aβ plaque deposition and memory deficits in AD mice.
Area of Science:
- Neuroscience
- Molecular Biology
- Cell Biology
Background:
- Alzheimer's disease (AD) pathogenesis involves amyloid precursor protein (APP) and amyloid beta (Aβ) accumulation.
- Mechanisms of APP sorting and lysosomal degradation are not fully understood.
- APP is processed in the Golgi and endosomes, leading to toxic Aβ generation.
Purpose of the Study:
- To investigate the role of the von Hippel-Lindau protein (VHL) in APP processing and degradation.
- To elucidate the mechanisms by which VHL influences APP trafficking and lysosomal degradation.
- To determine the impact of VHL on Alzheimer's disease pathology.
Main Methods:
- Studied the interaction between VHL and the cytoplasmic domain of APP.
- Investigated VHL-mediated ubiquitination of APP.
- Examined the effect of VHL on APP sorting into multivesicular bodies (MVBs) and lysosomal degradation.
- Utilized Alzheimer's disease model mice to assess the in vivo role of VHL.
Main Results:
- VHL recognizes and ubiquitinates the cytoplasmic domain of APP.
- VHL-mediated ubiquitination promotes APP sorting into intraluminal vesicles of MVBs.
- This sorting facilitates lysosomal degradation of APP.
- Loss of VHL accelerates Aβ plaque deposition and memory deficits in AD model mice.
Conclusions:
- VHL plays a critical role in restricting Alzheimer's disease pathogenesis.
- VHL facilitates APP degradation via ubiquitination-dependent MVB sorting and lysosomal pathways.
- Targeting VHL may offer a therapeutic strategy for Alzheimer's disease.
Related Concept Videos
Intralumenal Vesicles and Multivesicular Bodies
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Export of Misfolded Proteins out of the ER
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

